Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/13/2025

Infective Endocarditis Complications

Introduction to Complications

  • Heart failure is the most frequent complication of infective endocarditis (IE), occurring in 42-60% of native valve endocarditis cases, according to the European Society of Cardiology (ESC) guidelines 1
  • The European Society of Cardiology (ESC) recommends that heart failure be recognized as a major complication of IE, with a high incidence of 42-60% in native valve endocarditis cases 1

Clinical Presentation

  • Clinical presentation of heart failure in IE typically includes dyspnea, pulmonary edema, and cardiogenic shock, as stated by the European Society of Cardiology (ESC) guidelines 1
  • The European Society of Cardiology (ESC) reports that among patients with heart failure and IE, 66% present in New York Heart Association class III or IV 1
  • Moderate to severe heart failure is the most important predictor of in-hospital, 6-month, and 1-year mortality in IE patients, according to the European Society of Cardiology (ESC) guidelines 1

Diagnosis and Management

  • Echocardiography is crucial for the initial evaluation and follow-up of IE patients, including assessment of valve perforation, secondary mitral lesions, and aneurysms, as recommended by the European Society of Cardiology (ESC) guidelines 1
  • The European Society of Cardiology (ESC) indicates that surgical intervention is indicated for severe acute regurgitation causing pulmonary edema or cardiogenic shock, severe regurgitation with symptoms of heart failure, and locally uncontrolled infection 1
  • Repeat echocardiography is warranted when a patient develops worrisome clinical features during antibiotic therapy, including unexplained progression of heart failure symptoms, change in cardiac murmurs, and new atrioventricular block or arrhythmia, as stated by the American Heart Association (AHA) guidelines 2